Free Trial

Semtech (NASDAQ:SMTC) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.

Semtech logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Rep. Gilbert Ray Cisneros Jr. sold $1,001–$15,000 of Semtech shares on September 29, according to a filing disclosed October 12. He also made several other purchases and sales across technology, healthcare and industrial stocks.
  • Semtech reported strong recent results, with quarterly revenue rising 32.7% year over year to $341.87 million and EPS of $0.71 beating consensus by $0.10. Growth is being supported by demand for AI data-center connectivity and the company’s 1.6-terabit products.
  • Despite a consensus “Moderate Buy” rating and an average analyst price target of $212.47, valuation and insider selling remain concerns. Semtech shares were up 2.7%, while company insiders sold 13,737 shares worth about $2.27 million over the prior 90 days.
  • MarketBeat previews the top five stocks to own by November 1st.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Semtech Corporation (NASDAQ:SMTC). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Semtech stock on September 29th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $15,001 - $50,000 in shares of Benchmark Electronics NYSE: BHE on 10/1/2026.
  • Sold $1,001 - $15,000 in shares of Oxford Industries NYSE: OXM on 9/29/2026.
  • Sold $15,001 - $50,000 in shares of ITT NYSE: ITT on 9/29/2026.
  • Sold $1,001 - $15,000 in shares of BridgeBio Pharma NASDAQ: BBIO on 9/29/2026.
  • Purchased $1,001 - $15,000 in shares of Tandem Diabetes Care NASDAQ: TNDM on 9/29/2026.
  • Purchased $1,001 - $15,000 in shares of Cytokinetics NASDAQ: CYTK on 9/29/2026.
  • Purchased $1,001 - $15,000 in shares of Ultragenyx Pharmaceutical NASDAQ: RARE on 9/29/2026.
  • Purchased $1,001 - $15,000 in shares of YETI NYSE: YETI on 9/29/2026.
  • Sold $1,001 - $15,000 in shares of AtriCure NASDAQ: ATRC on 9/29/2026.
  • Purchased $1,001 - $15,000 in shares of Alkermes NASDAQ: ALKS on 9/29/2026.

Semtech Stock Up 2.7%

NASDAQ:SMTC opened at $172.78 on Wednesday. The company has a market cap of $16.13 billion, a price-to-earnings ratio of 114.42 and a beta of 2.41. The company has a current ratio of 1.70, a quick ratio of 1.31 and a debt-to-equity ratio of 0.47. Semtech Corporation has a twelve month low of $60.28 and a twelve month high of $201.99. The stock has a fifty day simple moving average of $156.05 and a 200-day simple moving average of $138.11.

Semtech (NASDAQ:SMTC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 25th. The semiconductor company reported $0.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.61 by $0.10. Semtech had a return on equity of 21.74% and a net margin of 13.11%. The firm had revenue of $341.87 million during the quarter, compared to analyst estimates of $328.67 million. During the same quarter in the previous year, the business earned $0.41 earnings per share. Semtech's quarterly revenue was up 32.7% on a year-over-year basis. Semtech has set its Q3 2027 guidance at 1.020-1.080 EPS. Analysts anticipate that Semtech Corporation will post 2.64 EPS for the current year.

Wall Street Analyst Weigh In

SMTC has been the topic of a number of recent research reports. TD Cowen increased their price target on Semtech from $210.00 to $215.00 and gave the stock a "buy" rating in a research report on Monday, June 22nd. New Street Research set a $230.00 target price on shares of Semtech in a research report on Thursday, August 20th. Wall Street Zen upgraded Semtech from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 29th. Seaport Research Partners initiated coverage on shares of Semtech in a research note on Tuesday, September 22nd. They issued a "buy" rating and a $200.00 target price for the company. Finally, Zacks Research upgraded shares of Semtech from a "hold" rating to a "strong-buy" rating in a report on Monday, September 21st. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $212.47.

Get Our Latest Stock Report on SMTC

Hedge Funds Weigh In On Semtech

A number of institutional investors have recently modified their holdings of SMTC. FNY Investment Advisers LLC grew its holdings in Semtech by 900.0% in the 2nd quarter. FNY Investment Advisers LLC now owns 200 shares of the semiconductor company's stock worth $32,000 after buying an additional 180 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Semtech in the second quarter worth about $32,000. Banque Cantonale Vaudoise acquired a new position in Semtech in the first quarter worth approximately $33,000. Allworth Financial LP acquired a new stake in shares of Semtech during the 2nd quarter valued at $55,000. Finally, Allied Private Wealth LLC acquired a new position in shares of Semtech in the 2nd quarter valued at $65,000.

Insider Activity

In related news, CFO Mark Lin sold 967 shares of the firm's stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $178.87, for a total value of $172,967.29. Following the transaction, the chief financial officer directly owned 35,999 shares in the company, valued at approximately $6,439,141.13. This trade represents a 2.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Rodolpho C. Cardenuto sold 5,321 shares of Semtech stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $165.00, for a total value of $877,965.00. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 13,737 shares of company stock worth $2,267,877. 0.44% of the stock is owned by corporate insiders.

Key Semtech News

Here are the key news stories impacting Semtech this week:

  • Positive Sentiment: Expanded manufacturing capacity supports AI growth. Semtech and Tower Semiconductor expanded their silicon-germanium manufacturing agreement, providing additional capacity for high-speed connectivity products used in AI data centers. The agreement strengthens supply support for Semtech’s expected demand growth. Tower Semiconductor, Semtech Extend SiGe Capacity Deal for AI Data Center Connectivity
  • Positive Sentiment: 1.6T product ramp is lifting the outlook. Semtech’s 1.6-terabit products are gaining traction as data centers upgrade optical connectivity for artificial intelligence workloads. Record revenue, increased optical-market share and strong customer demand support expectations for continued growth. Can Semtech’s 1.6T Ramp Accelerate its Data Center Growth?
  • Positive Sentiment: Recent fundamentals remain strong. Semtech’s latest reported quarter delivered revenue of $341.9 million, up 32.7% year over year, and EPS of $0.71 versus the $0.61 consensus estimate. Management’s approximately $410 million fiscal third-quarter revenue outlook reinforces the growth narrative.
  • Neutral Sentiment: Data Center Analyst Day is scheduled for October 15. Investors will look for updated details on the 1.6T ramp, customer demand, margins and longer-term AI infrastructure opportunities. The event could provide a catalyst but also raises the risk of disappointment if expectations are already high. Semtech Corporation to Host Data Center Analyst Day
  • Negative Sentiment: Valuation and insider activity are concerns. Northland Securities downgraded SMTC to Market Perform from Outperform, citing limited upside after the stock’s sharp rally. Reports also show repeated insider sales without purchases, including a recent sale by an executive. A law firm is soliciting shareholders over potential fiduciary-duty claims; this is an invitation to investigate, not evidence that wrongdoing occurred. Semtech Valuation Downgrade and Insider Activity Analysis

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Semtech Company Profile

(Get Free Report)

Semtech Corporation is a global semiconductor and technology company that designs and supplies analog and mixed-signal products for communications, industrial, automotive, consumer, and infrastructure applications. Its solutions are used to manage, protect, connect, and transmit data in electronic systems.

The company's portfolio includes signal-integrity products, protection devices, power-management components, optical and high-speed connectivity solutions, and video-processing technologies.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Semtech Right Now?

Before you consider Semtech, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semtech wasn't on the list.

While Semtech currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines